Ascentage Pharma recently unveiled promising clinical data on the use of Alrizomadlin as a monotherapy and in combination therapies for solid tumors at ASCO 2025. The presentation highlighted the company’s optimistic outlook and strategic plans for future developments in the pharmaceutical industry. Ascentage Pharma’s forward-looking statements, as per the regulations, express the company’s views on […]
Tag: clinical
Nxera Pharma Receives $15 Million from Neurocrine Biosciences for Phase 3 Trial of NBI-1117568
In a significant development, Nxera Pharma Group has secured a substantial investment of $15 million from Neurocrine Biosciences following the dosing of the first patient in the Phase 3 trial of NBI-1117568. This strategic alliance marks a crucial milestone in the discovery, development, and potential commercialization of innovative pharmaceutical products. However, investors should be aware […]
AAV Gene Therapy Vectors for Hemophilia
Recent research explores the theoretical risk of hepatocellular carcinoma (HCC) following adeno-associated virus (AAV) gene therapy in hemophilia patients. While data from clinical trials are reassuring, concerns remain about long-term oncogenic potential. A single case of HCC post AAV infusion in a patient with prior HCV infection raised questions, but further analysis suggested AAV integration […]
